The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.

Illumina is reducing its forecast for this year’s financial performance and cutting $100 million in spending because China ...

China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina , just minutes ...

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...

Illumina shareholders received a warning shot. In response to President Trump’s initial tariff measures, the Chinese ...

In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...